Article Text

PDF
Phenotypic spectrum of CHARGE syndrome in fetuses with CHD7 truncating mutations correlates with expression during human development
  1. D Sanlaville1,*,
  2. H C Etchevers1,*,
  3. M Gonzales2,*,
  4. J Martinovic1,
  5. M Clément-Ziza1,
  6. A-L Delezoide3,
  7. M-C Aubry4,
  8. A Pelet1,
  9. S Chemouny4,
  10. C Cruaud5,
  11. S Audollent1,
  12. C Esculpavit1,
  13. G Goudefroye1,
  14. C Ozilou1,
  15. C Fredouille2,
  16. N Joye2,
  17. N Morichon-Delvallez1,
  18. Y Dumez4,
  19. J Weissenbach5,
  20. A Munnich1,
  21. J Amiel1,
  22. F Encha-Razavi1,
  23. S Lyonnet1,
  24. M Vekemans1,
  25. T Attié-Bitach1
  1. 1Département de Génétique et Unité INSERM U-393, Hôpital Necker-Enfants Malades, AP-HP, 75015 Paris, France
  2. 2Unité de Foetopathologie, Hôpital Saint Antoine, AP-HP, 75012 Paris, France
  3. 3Service de Biologie du Développement, Hôpital Robert Debré, AP-HP, 75019 Paris, France
  4. 4Service d’Obstétrique, Hôpital Necker-Enfants Malades, AP-HP, 75015 Paris, France
  5. 5Genoscope and CNRS UMR8030, Evry, France
  1. Correspondence to:
 T Attié-Bitach
 Département de Génétique et Unité INSERM U-393, Hôpital Necker-Enfants Malades, 149, rue de Sèvres, 75743 Paris Cedex 15, France; tania.attie{at}necker.fr

Abstract

Background: The acronym CHARGE refers to a non-random cluster of malformations including coloboma, heart malformation, choanal atresia, retardation of growth and/or development, genital anomalies, and ear anomalies. This set of multiple congenital anomalies is frequent, despite rare patients with normal intelligence, and prognosis remains poor. Recently, CHD7 gene mutations have been identified in CHARGE patients; however, the function of CHD7 during development remains unknown.

Methods: We studied a series of 10 antenatal cases in whom the diagnosis of CHARGE syndrome was suspected, considering that a careful pathological description would shed light on the CHD7 function during development. CHD7 sequence analysis and in situ hybridisation were employed.

Results: The diagnosis of CHARGE syndrome was confirmed in all 10 fetuses by the identification of a CHD7 heterozygous truncating mutation. Interestingly, arhinencephaly and semi-circular canal agenesis were two constant features which are not included in formal diagnostic criteria so far. In situ hybridisation analysis of the CHD7 gene during early human development emphasised the role of CHD7 in the development of the central nervous system, internal ear, and neural crest of pharyngeal arches, and more generally showed a good correlation between specific CHD7 expression pattern and the developmental anomalies observed in CHARGE syndrome.

Conclusions: These results allowed us to further refine the phenotypic spectrum of developmental anomalies resulting from CHD7 dysfunction.

  • CHARGE syndrome
  • CHD7 gene
  • development
  • gene expression pattern
  • human embryogenesis

Statistics from Altmetric.com

Footnotes

  • * These authors contributed equally to this work

  • Published Online First 23 September 2005

  • DS was supported by the Programme de Recherche Clinique AOM 02-122. HCE was supported by the Association Française contre les Myopathies and the INSERM Avenir program

  • Competing interests: none declared

  • Consent has been given for the publication of the details in this report

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.